Kala Bio Inc. KALA on Monday said it has commercially launched its first enterprise AI product, delivering on a two-week timeline. CEO Avi Minkowitz said the rollout of the Bionic Intelligence ...

Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...

Top: SEAMOUR, the robotic sea lion. Bottom: Its digital twin. A Drexel Engineering team has developed a highly accurate numerical model that predicts how their bio-robotic sea lion swims and maneuvers ...

Company and CMMI agreed to key terms to be offered to State Medicaid Agencies to support access to LYFGENIA™ gene therapy for sickle cell disease States can opt in to an outcomes-based agreement with ...

UBC Okanagan researchers have developed a 3D bio-printed model that closely mimics the complexity of natural lung tissue, an innovation that could transform how scientists study lung disease and ...

CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.

OXFORD, England--(BUSINESS WIRE)--Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

The business model will focus on selling 3D bio-printers and bio-inks designed to develop delicious, nutritious, safe, and consistent cultivated meat from ethically harvested cells. 3D bio-printers: ...

The previous blog briefly reviewed George Engel’s famous proposal for medicine to adopt a biopsychosocial lens. Being a holistic thinker, I support Engel’s call for medical professionals in general ...